AVR · Anteris Technologies Global Corp.
$8.98
-0.27 (-2.92%)
At close · Aug 21
Market Cap
$901.49M
Shares
97.46M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.91M
-29.2%
FY2025
Net Income
-$94.14M
-23.4%
FY2025
Gross Margin
70.26%
+23.4pp
FY2025
Operating Margin
-4908.21%
-2008.8pp
FY2025
Diluted EPS
-$2.55
+30.7%
FY2025
Operating Cash Flow
-$77.8M
-27%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| $2.24M | $1.91M | $2.7M | |
| $561K | $569K | $1.44M | |
| $1.68M | $1.34M | $1.27M | |
| — | 70.26% | 46.84% | |
| $77.15M | $69.12M | $51.45M | |
| $30.77M | $26.12M | $28.19M | |
| — | $1.66M | $1.51M | |
| -$106.23M | -$93.89M | -$78.37M | |
| — | -4908.21% | -2899.45% | |
| — | -$92.23M | -$76.87M | |
| $4.37M | $467K | $2.44M | |
| -$102.42M | -$94.23M | -$75.97M | |
| $492K | $0 | $0 | |
| -$103.5M | -$94.14M | -$76.29M | |
| — | -4921.28% | -2822.46% | |
| $657K | -$81K | $324K | |
| -$103.43M | -$93.53M | -$77.63M | |
| USD/shares | — | -$2.55 | -$3.68 |
| USD/shares | — | -$2.55 | -$3.68 |
| shares | — | 36.91M | 20.25M |
| shares | — | 36.91M | 20.25M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 3.04×
EV/EBIT
—
Peer median 30.98×
P/E (TTM)
—
Peer median 31.87×
Peer medians compare against the 23 similar-size Medical Instruments & Supplies companies (of 48 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| Anteris Business Segment | $1,913,000 | $2,703,000 |
By Geography (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| United States | $1,608,000 | $1,782,000 |
| Germany | $272,000 | $900,000 |
| Australia | $33,000 | $21,000 |
| Switzerland | $0 | $0 |
| Sweden | $0 | $0 |
By Product & Service (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| ADAPT Tissue Products | $1,913,000 | $2,703,000 |
Key facts
CIK
2011514
CUSIP
03675P102
13F (30d)
131 filings
125 filers
Visit website
Investor relations